Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS

被引:242
作者
Alimonti, JB [1 ]
Ball, TB [1 ]
Fowke, KR [1 ]
机构
[1] Univ Manitoba, Dept Med Microbiol & Infect Dis, Winnipeg, MB R3E 0W3, Canada
关键词
D O I
10.1099/vir.0.19110-0
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
AIDS, caused by the retroviruses human immunodeficiency virus type 1 and type 2 (HIV-1 and HIV-2), has reached pandemic proportions. Therefore, it is critical to understand how HIV causes AIDS so that appropriate therapies can be formulated. Primarily, HIV infects and kills CD4(+) T lymphocytes, which function as regulators and amplifiers of the immune response. In the absence of effective anti-retroviral therapy, the hallmark decrease in CD4(+) T lymphocytes during AIDS results in a weakened immune system, impairing the body's ability to fight infections or certain cancers such that death eventually ensues. The major mechanism for CD4(+) T cell depletion is programmed cell death (apoptosis), which can be induced by HIV through multiple pathways. Death of HIV-infected cells can result from the propensity of infected lymphocytes to form short-lived syncytia or from an increased susceptibility of the cells to death. However, the apoptotic cells appear to be primarily uninfected bystander cells and are eradicated by two different mechanisms: either a Fas-mediated mechanism during activation-induced cell death (AICD), or as a result of HIV proteins (Tat, gp120, Nef, Vpu) released from infected cells stimulating apoptosis in uninfected bystander cells. There is also evidence that as AIDS progresses cytokine dysregulation occurs, and the overproduction of type-2 cytokines (IL-4, IL-10) increases susceptibility to ACID whereas type-1 cytokines (IL-12, IFN-gamma) may be protective. Clearly there are multiple causes of CD4(+) T lymphocyte apoptosis in AIDS and therapies that block or decrease that death could have significant clinical benefit.
引用
收藏
页码:1649 / 1661
页数:13
相关论文
共 152 条
  • [91] Ligation of human CD4 interferes with antigen-induced activation of primary T cells
    Marschner, S
    Hünig, T
    Cambier, JC
    Finkel, TH
    [J]. IMMUNOLOGY LETTERS, 2002, 82 (1-2) : 131 - 139
  • [92] CD4(+) T-CELLS ARE REQUIRED TO SUSTAIN CD8(+) CYTOTOXIC T-CELL RESPONSES DURING CHRONIC VIRAL-INFECTION
    MATLOUBIAN, M
    CONCEPCION, RJ
    AHMED, R
    [J]. JOURNAL OF VIROLOGY, 1994, 68 (12) : 8056 - 8063
  • [93] IDENTIFICATION OF TARGET ANTIGENS FOR THE HUMAN CYTOTOXIC T-CELL RESPONSE TO EPSTEIN-BARR-VIRUS (EBV) - IMPLICATIONS FOR THE IMMUNE CONTROL OF EBV-POSITIVE MALIGNANCIES
    MURRAY, RJ
    KURILLA, MG
    BROOKS, JM
    THOMAS, WA
    ROWE, M
    KIEFF, E
    RICKINSON, AB
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (01) : 157 - 168
  • [94] FAS AND FAS LIGAND - LPR AND GLD MUTATIONS
    NAGATA, S
    SUDA, T
    [J]. IMMUNOLOGY TODAY, 1995, 16 (01): : 39 - 43
  • [95] Interleukin-15 is a potent survival factor in the prevention of spontaneous but not CD95-induced apoptosis in CD4 and CD8 T lymphocytes of HIV-infected individuals. Correlation with its ability to increase BCL-2 expression
    Naora, H
    Gougeon, ML
    [J]. CELL DEATH AND DIFFERENTIATION, 1999, 6 (10) : 1002 - 1011
  • [96] Human immunodeficiency virus type 1 Tat protein induces death by apoptosis in primary human neuron cultures
    New, DR
    Ma, MH
    Epstein, LG
    Nath, A
    Gelbard, HA
    [J]. JOURNAL OF NEUROVIROLOGY, 1997, 3 (02) : 168 - 173
  • [97] HIV-1 protease processes procaspase 8 to cause mitochondrial release of cytochrome c, caspase cleavage and nuclear fragmentation
    Nie, Z
    Phenix, BN
    Lum, JJ
    Alam, A
    Lynch, DH
    Beckett, B
    Krammer, PH
    Sekaly, RP
    Badley, AD
    [J]. CELL DEATH AND DIFFERENTIATION, 2002, 9 (11) : 1172 - 1184
  • [98] Insufficient interleukin-2 production from splenic CD4+ T cells causes impaired cell proliferation and early apoptosis in SAMP1, a strain of senescence-accelerated mouse
    Nishimura, Y
    Hosokawa, T
    Hosono, M
    Baba, M
    Hosokawa, M
    [J]. IMMUNOLOGY, 2002, 107 (02) : 190 - 198
  • [99] Regulation of T-cell apoptosis: a mixed lymphocyte reaction model
    O'Flaherty, E
    Wong, WK
    Pettit, SJ
    Seymour, K
    Ali, S
    Kirby, JA
    [J]. IMMUNOLOGY, 2000, 100 (03) : 289 - 299
  • [100] Tumor-specific targeting of T helper type 1 (Th1) cells by anti-CD3 x anti-c-ErbB-2 bispecific antibody
    Ohmi, Y
    Shiku, H
    Nishimura, T
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 1999, 48 (08) : 456 - 462